Mildly elevated serum total bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons with type 2 diabetes

Clinical and Experimental Hypertension

Volumn 38, Issue 1, 2016, Pages 107-112

  Kawamoto, Ryuichi ^a,b   Ninomiya, Daisuke ^a,b   Hasegawa, Yoichi ^a,b   Kasai, Yoshihisa ^b   Kusunoki, Tomo ^b   Ohtsuka, Nobuyuki ^b   Kumagi, Teru ^a   Abe, Masanori ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Atherosclerosis; carotid artery; confounding factor; Serum total bilirubin; type 2 diabetes; ultrasonography

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BILIRUBIN BLOOD LEVEL; CAROTID ATHEROSCLEROSIS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK ASSESSMENT; SMOKING; BLOOD; CAROTID ARTERY DISEASES; COMORBIDITY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; JAPAN; ODDS RATIO; PREVALENCE; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BILIRUBIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAPAN; MALE; ODDS RATIO; PREVALENCE; RISK ASSESSMENT;

EID: 84954401132     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2015.1060990     Document Type: Article

References (37)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20
2. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-23
3. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-4
4. Myung SK, Ju W, Cho B, et al., Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomized controlled trials. BMJ 2013; 346: f10
5. Sung KC, Shin J, Lim YH, et al. Relation of conjugated bilirubin concentrations to the presence of coronary artery calcium. Am J Cardiol 2013; 112: 1873-9
6. Kang SJ, Kim D, Park HE, et al. Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis 2013; 230: 242-8
7. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-6
8. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-67
9. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010; 30: 182-5
10. Thapar A, Jenkins IH, Mehta A, Davies AH. Diagnosis and management of carotid atherosclerosis. BMJ 2013; 346: f1485
11. Sun Y, Lin CH, Lu CJ, et al. Carotid atherosclerosis, intima media thickness and risk factors-an analysis of 1781 asymptomatic subjects in Taiwan. Atherosclerosis 2002; 164: 89-94
12. Kawamoto R, Tomita H, Oka Y, et al. Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med 2005; 44: 787-93
13. Kawamoto R, Oka Y, Tomita H, Kodama A. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly. J Atheroscler Thromb 2005; 12: 143-8
14. Takayama S, Kawamoto R, Kusunoki T, et al. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 2012; 11: 2
15. Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006; 184: 431-7
16. Vítek L, Novotný L, Sperl M, et al. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 2006; 21: 408-14
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
18. Levey AS, Coresh J, Greene T, et al., Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-54
19. Imai E, Horio M, Nitta K, et al. Modification of the MDRD study equation for Japan. Am J Kidney Dis 2007; 50: 927-37
20. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arter Throm 1991; 11: 1245-9
21. Sidhu PS, Desai SR. A simple and reproducible method for assessing intima-media thickness of the common carotid artery. Br J Radiol 1997; 70: 85-89
22. Kawamoto R, Tomita H, Ohtsuka N, et al. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 2007; 14: 78-85
23. Inoguchi T, Sasaki S, Kobayashi K, et al. Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 2007; 298: 1398-400
24. Fukui M, Tanaka M, Yamazaki M, et al. Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetes. Diabet Med 2011; 28: 96-9
25. Yasuda M, Kiyohara Y, Wang JJ, et al. High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology 2011; 118: 1423-8
26. Han SS, Na KY, Chae DW, et al. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J Exp Med 2010; 221: 133-40
27. Fukui M, Tanaka M, Shiraishi E, et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008; 74: 1197-201
28. Schwertner HA. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 1998; 136: 383-7
29. Madhavan M, Wattigney WA, Srinivasan SR, et al. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997; 131: 107-13
30. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem 1994; 269: 16712-19
31. Siow RC, Sato H, Mann GE. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 1999; 41: 385-94
32. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478
33. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74
34. Gopaul NK, Anggard EE, Mallet AI, et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995; 368: 225-9
35. Rodriguez-Moran M, Guerrero-Romero F. Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control. J Endocrinol Invest 2003; 26: 216-21
36. Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol 2013; 18: 53-6
37. Lee YH, Shin MH, Kweon SS, et al. Alcohol consumption and carotid artery structure in Korean adults aged 50 years and older. BMC Public Health 2009; 9: 358